Lawrence Dierickx

406 total citations
33 papers, 275 citations indexed

About

Lawrence Dierickx is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lawrence Dierickx has authored 33 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lawrence Dierickx's work include Neuroendocrine Tumor Research Advances (16 papers), Lung Cancer Research Studies (15 papers) and Medical Imaging Techniques and Applications (11 papers). Lawrence Dierickx is often cited by papers focused on Neuroendocrine Tumor Research Advances (16 papers), Lung Cancer Research Studies (15 papers) and Medical Imaging Techniques and Applications (11 papers). Lawrence Dierickx collaborates with scholars based in France, United States and Belgium. Lawrence Dierickx's co-authors include F. Courbon, Slimane Zerdoud, Tarik Belhocine, Karoline Spaepen, Patrick Flamen, Cathérine Castaigne, Pierre Bourgeois, Axel Bossuyt, Tony Lahoutte and Cyril Jaudet and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Physics in Medicine and Biology.

In The Last Decade

Lawrence Dierickx

32 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Dierickx France 10 127 93 65 50 47 33 275
Toshimi Sato Japan 10 157 1.2× 62 0.7× 35 0.5× 78 1.6× 47 1.0× 25 367
Brian D. Acker Canada 8 59 0.5× 99 1.1× 89 1.4× 75 1.5× 61 1.3× 9 334
Harald Eidherr Austria 12 281 2.2× 102 1.1× 36 0.6× 180 3.6× 24 0.5× 17 423
Eric von Benzon Denmark 9 205 1.6× 191 2.1× 160 2.5× 106 2.1× 47 1.0× 15 414
Britta Langen Sweden 12 192 1.5× 79 0.8× 72 1.1× 82 1.6× 13 0.3× 33 372
C. Zwarthoed France 5 175 1.4× 93 1.0× 15 0.2× 114 2.3× 44 0.9× 12 329
Dominique Slaets Belgium 8 140 1.1× 79 0.8× 31 0.5× 47 0.9× 19 0.4× 8 304
Sofia C. Vaz Portugal 12 245 1.9× 95 1.0× 31 0.5× 176 3.5× 61 1.3× 36 429
J.A. Burgers Netherlands 13 67 0.5× 141 1.5× 67 1.0× 396 7.9× 41 0.9× 25 566
G. McVey Ireland 13 160 1.3× 68 0.7× 22 0.3× 182 3.6× 36 0.8× 28 336

Countries citing papers authored by Lawrence Dierickx

Since Specialization
Citations

This map shows the geographic impact of Lawrence Dierickx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Dierickx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Dierickx more than expected).

Fields of papers citing papers by Lawrence Dierickx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Dierickx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Dierickx. The network helps show where Lawrence Dierickx may publish in the future.

Co-authorship network of co-authors of Lawrence Dierickx

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Dierickx. A scholar is included among the top collaborators of Lawrence Dierickx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Dierickx. Lawrence Dierickx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dierickx, Lawrence, et al.. (2024). Evaluation of a blood miRNA/mRNA signature to follow-up Lu-PRRT therapy for G1/G2 intestinal neuroendocrine tumors. Frontiers in Endocrinology. 15. 1385079–1385079. 2 indexed citations
2.
Hadoux, Julien, Pauline Afchain, Anne‐Ségolène Cottereau, et al.. (2024). Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network. Journal of Nuclear Medicine. 65(9). 1416–1422. 2 indexed citations
3.
4.
Chaltiel, Léonor, et al.. (2024). Insertion of synthetic lesions on patient data: a method for evaluating clinical performance differences between PET systems. EJNMMI Physics. 11(1). 9–9. 1 indexed citations
5.
Rozenblum, Laura, Delphine Vezzosi, M. Thoulouzan, et al.. (2023). Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas. Cancers. 15(18). 4666–4666. 3 indexed citations
6.
Navalkissoor, Shaunak, Rajaventhan Srirajaskanthan, F. Courbon, et al.. (2022). Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. 49(10). 3529–3537. 14 indexed citations
7.
Cattaneo, Marco, Lawrence Dierickx, Péter Igaz, et al.. (2021). Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers. 13(24). 6290–6290. 7 indexed citations
8.
9.
Rozenblum, Laura, Fatima‐Zohra Mokrane, Randy Yeh, et al.. (2019). Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach. European Journal of Radiology. 122. 108743–108743. 8 indexed citations
10.
Dierickx, Lawrence, et al.. (2019). Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 63(3). 284–291. 3 indexed citations
11.
Courbon, F., et al.. (2019). Diagnosis of an intestinal mucormycosis ‘fungus ball’ located with PET/CT with [18F] FDG-PET/CT. SHILAP Revista de lepidopterología. 3(1). 21–21. 3 indexed citations
12.
Puszkiel, Alicja, et al.. (2018). Evaluation of the Interaction of Amino Acid Infusion on 177Lu-Dotatate Pharmacokinetics in Patients with Gastroenteropancreatic Neuroendocrine Tumors. Clinical Pharmacokinetics. 58(2). 213–222. 10 indexed citations
13.
Massabeau, Carole, Jonathan Khalifa, Thomas Filleron, et al.. (2017). Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non–Small-cell Lung Cancer: A Phase I Study. Clinical Lung Cancer. 19(3). e277–e285. 21 indexed citations
14.
Chaltiel, Léonor, et al.. (2017). A clinical evaluation of the impact of the Bayesian penalized likelihood reconstruction algorithm on PET FDG metrics. Nuclear Medicine Communications. 38(11). 979–984. 18 indexed citations
15.
Jaudet, Cyril, et al.. (2014). Comparison of an alternative and existing binning methods to reduce the acquisition duration of 4D PET/CT. Medical Physics. 41(11). 112503–112503. 3 indexed citations
16.
Dercle, Laurent, Roland Chisin, Samy Ammari, et al.. (2014). Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: Are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?. European Journal of Nuclear Medicine and Molecular Imaging. 42(3). 397–408. 16 indexed citations
17.
Batatia, Hadj, et al.. (2012). The retrospective binning method improves the consistency of phase binning in respiratory-gated PET/CT. Physics in Medicine and Biology. 57(23). 7829–7841. 21 indexed citations
18.
Dierickx, Lawrence, Hendrik Everaert, Philippe Deron, et al.. (2003). Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-α-methyl tyrosine and single photon emission tomography. Nuclear Medicine Communications. 24(6). 633–641. 3 indexed citations
19.
20.
Flamen, Patrick, et al.. (1997). Fascial Tc-99m MDP Uptake in Eosinophilic Fasciitis as Demonstrated by SPECT. Clinical Nuclear Medicine. 22(12). 844–846. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshimi Sato Breakdown of academic impact, for papers by Brian D. Acker Breakdown of academic impact, for papers by Harald Eidherr Breakdown of academic impact, for papers by Eric von Benzon Breakdown of academic impact, for papers by Britta Langen Breakdown of academic impact, for papers by C. Zwarthoed Breakdown of academic impact, for papers by Dominique Slaets Breakdown of academic impact, for papers by Sofia C. Vaz Breakdown of academic impact, for papers by J.A. Burgers Breakdown of academic impact, for papers by G. McVey
Rankless by CCL
2026